FOXA1 and ER expression are positively correlated in breast cancer, and the vast majority of ER-conducting signals require FOXA1 binding to chromatin for activation, leading to complete suppression of ER transcriptional activity when FOXA1 is absent [14, 103, 104]. This evidence concerns the gene FOXA1 and breast carcinoma.